신경혈전제거 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Neurothrombectomy Devices Market Growth & Trends:

The global neurothrombectomy devices market size is expected to reach USD 1.1 billion by 2030, registering a CAGR of 6.94% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

Neurothrombectomy Devices Market Report Highlights:

• Based on products, clot retrievers segment dominated the market in 2024, with a share of 57.8% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players.
• Based on end-use, hospital segment dominated the market in 2024 with a share of 70.4% due to improving health care facilities and the availability of advanced equipment in the hospitals.
• Europe led the market with the maximum revenue share of 32.9% in 2024, owing to the increasing number of patients suffering from acute ischemic stroke in this region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Neurothrombectomy Devices Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Neurothrombectomy Devices Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of suppliers
    • 3.4.1.2. Bargaining power of buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political Landscape
    • 3.4.2.2. Economic and Social Landscape
    • 3.4.2.3. Technological Landscape
    • 3.4.2.4. Environmental Landscape
    • 3.4.2.5. Legal Landscape

Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Neurothrombectomy Devices Market: Product Movement Analysis, 2024 & 2030 (USD Million)
• 4.3. Clot Retrievers
  • 4.3.1. Clot Retrievers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Aspiration/Suction Devices
  • 4.4.1. Aspiration/Suction Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Vascular Snares
  • 4.5.1. Vascular Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurothrombectomy Devices Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Neurothrombectomy Devices Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Emergency Clinics
  • 5.4.1. Emergency Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Ambulatory Surgical Centers
  • 5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis

• 6.1. Neurothrombectomy Devices Market Share, By Region, 2024 & 2030 (USD Million)
• 6.2. North America
  • 6.2.1. North America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. Key Country Dynamics
    • 6.2.2.2. Regulatory Landscape/Reimbursement Structure
    • 6.2.2.3. Competitive Scenario
    • 6.2.2.4. U.S. Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.3. Canada
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. Regulatory Landscape/Reimbursement Structure
    • 6.2.3.3. Competitive Scenario
    • 6.2.3.4. Canada Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.2.4. Mexico
    • 6.2.4.1. Key Country Dynamics
    • 6.2.4.2. Regulatory Landscape/Reimbursement Structure
    • 6.2.4.3. Competitive Scenario
    • 6.2.4.4. Mexico Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. Europe Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. UK
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.2.3. Competitive Scenario
    • 6.3.2.4. UK Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Germany
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.3.3. Competitive Scenario
    • 6.3.3.4. Germany Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.4. France
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.4.3. Competitive Scenario
    • 6.3.4.4. France Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.5. Italy
    • 6.3.5.1. Key Country Dynamics
    • 6.3.5.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.5.3. Competitive Scenario
    • 6.3.5.4. Italy Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.6. Spain
    • 6.3.6.1. Key Country Dynamics
    • 6.3.6.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.6.3. Competitive Scenario
    • 6.3.6.4. Spain Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.7. Denmark
    • 6.3.7.1. Key Country Dynamics
    • 6.3.7.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.7.3. Competitive Scenario
    • 6.3.7.4. Denmark Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.8. Sweden
    • 6.3.8.1. Key Country Dynamics
    • 6.3.8.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.8.3. Competitive Scenario
    • 6.3.8.4. Sweden Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.9. Norway
    • 6.3.9.1. Key Country Dynamics
    • 6.3.9.2. Regulatory Landscape/Reimbursement Structure
    • 6.3.9.3. Competitive Scenario
    • 6.3.9.4. Norway Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.2.3. Competitive Scenario
    • 6.4.2.4. Japan Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. China
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.3.3. Competitive Scenario
    • 6.4.3.4. China Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. India
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.4.3. Competitive Scenario
    • 6.4.4.4. India Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.5. Australia
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.5.3. Competitive Scenario
    • 6.4.5.4. Australia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.6. Thailand
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.6.3. Competitive Scenario
    • 6.4.6.4. Thailand Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.7. South Korea
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Regulatory Landscape/Reimbursement Structure
    • 6.4.7.3. Competitive Scenario
    • 6.4.7.4. South Korea Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. Latin America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. Brazil
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Landscape/Reimbursement Structure
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. Brazil Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Argentina
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Landscape/Reimbursement Structure
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Argentina Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Middle East and Africa
  • 6.6.1. Middle East and Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Landscape/Reimbursement Structure
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. South Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Landscape/Reimbursement Structure
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Saudi Arabia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. UAE
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Landscape/Reimbursement Structure
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. UAE Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Kuwait
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Landscape/Reimbursement Structure
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Kuwait Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Medtronic
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/ Strategic Initiatives
  • 7.4.2. Stryker
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/ Strategic Initiatives
  • 7.4.3. Acandis GmbH
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/ Strategic Initiatives
  • 7.4.4. Phenox GmbH
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/ Strategic Initiatives
  • 7.4.5. Penumbra
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/ Strategic Initiatives
  • 7.4.6. Vesalio, LLC.
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/ Strategic Initiatives
  • 7.4.7. Terumo Corporation
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/ Strategic Initiatives
  • 7.4.8. MIVI Neuroscience, Inc.
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/ Strategic Initiatives
  • 7.4.9. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/ Strategic Initiatives
  • 7.4.10. Rapid Medical
    • 7.4.10.1. Participant's Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Recent Developments/ Strategic Initiatives
  • 7.4.11. Infinity Neuro
    • 7.4.11.1. Participant's Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Product Benchmarking
    • 7.4.11.4. Recent Developments/ Strategic Initiatives